In April, on Gordon’s 22nd birthday, he was told he had epithelioid sarcoma, a cancer so rare that Americans have a better chance - a much better chance - of being struck by lightning.

ANN ARBOR, Mich., Oct. 12, 2021 /PRNewswire/ -- Patients diagnosed with a rare cancer called Epithelioid Sarcoma face many challenges that will impact their outcome, beginning with the lengthy ...

Epithelioid sarcoma is an incredibly rare form of soft tissue cancer found most often under the skin of a finger, hand, forearm, lower leg or foot.

Kristi Loyall created the @onefootwander Instagram account to share funny photos of her amputated foot ... “They told me it was epithelioid sarcoma, which is a type of soft-tissue sarcoma ...

Epithelioid sarcoma is a distinctive, rare soft tissue sarcoma that typically involves the distal extremities in young adults, and shows epithelioid morphology and immunohistochemical markers of ...

Epithelioid Tumors Have Improved Chemotherapy Response by Dr. Trupti Shirole on Jun 23 2023 11:13 PM. Listen to this article. 0:00 / 0:00. Highlights: ...

CNN — Leila Janah, a fierce entrepreneur who worked to help those living below the poverty line, died in January from complications of epithelioid sarcoma -- a form of cancer. She was 37. In a ...

Epithelioid sarcoma, a rare aggressive cancer that usually strikes young adults, and rhabdoid tumors, which affect children, have long been difficult to treat.But the outlook for people with these ...

Epithelioid hemangioendothelioma is an extremely unusual type of vascular tumor that invades the epithelial cells, which line the inside of blood vessels. These tumors typically grow slowly over years ...

Eleven years after it was founded, the Cambridge biopharmaceutical startup Epizyme on Thursday sought early approval of an experimental medicine to treat an ultra-rare form of cancerous tumors. If ...

Leila Janah, a fierce entrepreneur who worked to help those living below the poverty line, died in January from complications of epithelioid sarcoma – a form of cancer. She was 37. In a November ...

Epizyme on Thursday sought early approval of an experimental medicine to treat an ultra-rare form of cancerous tumors. If successful, the drug would be the company’s first to reach the market.